AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2

  • AnPac Bio-Medical Science Co Ltd ANPC has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H of 2020. 
  • For 2Q, total paid tests and paid cancer tests increased approximately 280% Q/Q and around 270%, respectively.
  • The Company expects that the strong test volume growth will continue throughout this year.
  • Price Action: ANPC shares are up 9.5% at $4.39 during the premarket session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!